APA

Tong Y., Zhu W., Huang X., You L., Han X., Yang C. & Qian W. (20141028). PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus. : Oncology reports.

Chicago

Tong Yin, Zhu Weiwei, Huang Xianbo, You Liangshun, Han Xiujun, Yang Chunmei and Qian Wenbin. 20141028. PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus. : Oncology reports.

Harvard

Tong Y., Zhu W., Huang X., You L., Han X., Yang C. and Qian W. (20141028). PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus. : Oncology reports.

MLA

Tong Yin, Zhu Weiwei, Huang Xianbo, You Liangshun, Han Xiujun, Yang Chunmei and Qian Wenbin. PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus. : Oncology reports. 20141028.